GlassScriptPhysician profile
Ramin R Tabaddor
NPI 1548294291
$12,993.52
in general payments reported to CMS, 2019-2025
6 companies · $93.10 in 2025
The $93.10 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.78 · 2020: $53.35 · 2021: $6,517 · 2022: $1,000 · 2023: $5,202 · 2024: $96.77 · 2025: $93.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,750 · Travel and Lodging: $1,251 · Food and Beverage: $391.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,750.00 |
| Travel and Lodging | $1,250.74 |
| Food and Beverage | $391.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $9,631.24 | 2020-2023 | |
| Kairos Surgical INC | $3,031.77 | 2021-2023 | |
| Smith+Nephew, INC. | $189.87 | 2024-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Accu-Pass |
| Stryker Corporation | $109.86 | 2023 | Cinchlock, Nanotack Flex, Hipcheck |
| Bioventus LLC | $19.39 | 2019 | |
| Pacira Therapeutics, INC. | $11.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramin Tabaddor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.